1Hemalatha V, Padma M, Sekar U, et al. Detection of AmpC beta lactamases production in Escherichia coli & Klebsiella by an inhibitor based method [ J ]. Indian J Med Res, 2007, 126(3) :220-223.
3Schmidtke A J, Hanson ND. Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance [ J ]. Antimicrob Agents Chemother, 2006, 50(6):2030-2037.
7Mocktar C, Govinden U, Sturm AW, et al. CMY- 20, a novel AmpC-type β-1actamase from South African clinical Escherichia coli isolates [ J ]. Diagn Microbiol Infect Dis, 2008, 60(4) : 405-408.
8Li Y, Li Q, Du Y, et al. Prevalence of plasmid- mediated AmpC β-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2- Type AmpC β-lactamase resistance in China [ J ]. Clin Microbiol, 2008, 46(4) : 1317-1321.
9Fey PD, Safranek TJ, Rupp ME, et al. Ceftriaxone- resistant salmonella infection acquired by a child from cattle [J]. N Engl J Med, 2000, 342(17): 1242- 1249.
7[4]Fonineau N,Poirel L,Nordmann P.Plasmid-mediated and inducible cephalo8pOrina8e DHA-2 from Klebsiella pneumoniae[J].Antimicrob Chemother,2001,47 (2):207-210.
8[5]Fotfineau N,Naas T,Nordmann P,等.SHV-type extended-spectrum beta-laetamase in a Shigella flexneri clinical isolate[J].Antimicrob Chemother,2001,47 (5):685-688.
9[6]Literaeka E,Empel J.Four variants of the Citrobactar freundii AmpC-type eephalosporinases.including novel enzymes CMY-14 and CMY-15.in a Proteus mirabilis clone widespread in Pol and[J].Antimicrob Agents Chemother 2004,48 (11):4136-4143.
10[7]Nakano R,Okamoto R,Nakano Y,et al.CFE-1,a novel plasmid-encoded AmpC beta-lactamases with an ampR gene originating from Citrobacter freundii[J].Antimicrob Agents Chemother,2004,48 (4):1151-1158.
